StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of CALA stock opened at $0.02 on Tuesday. Calithera Biosciences has a 52-week low of $0.01 and a 52-week high of $0.50. The stock’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.03.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- How to Invest in Blue Chip Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Use Stock Screeners to Find Stocks
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
